Guidance for Nevro (NVRO)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2024 | N/A | N/A | $400.00M – 405.00M | $402.60M | = Maintained | Details |
| 2024 | N/A | N/A | $400.00M – 405.00M | $439.90M | = Maintained | Details |
| Q2 2024 | N/A | N/A | $106.00M – 108.00M | $111.40M | = Maintained | Details |
| 2023 | N/A | N/A | $445.00M – 455.00M | $448.90M | = Maintained | Details |
| Q2 2023 | N/A | N/A | $110.00M – 112.00M | $111.50M | = Maintained | Details |
| 2022 | N/A | N/A | $415.00M – 430.00M | $422.30M | = Maintained | Details |
| Q2 2022 | N/A | N/A | $103.00M – 106.00M | $104.40M | = Maintained | Details |
| 2021 | N/A | N/A | $430.00M – 450.00M | $452.00M | = Maintained | Details |
| Q4 2021 | N/A | N/A | $94.00M – 98.00M | $111.00M | = Maintained | Details |
| 2020 | N/A | N/A | $435.00M – 440.00M | $437.06M | = Maintained | Details |
| 2019 | N/A | N/A | $368.00M – 374.00M | $366.97M | = Maintained | Details |
| 2019 | N/A | N/A | $400.00M – 410.00M | $419.30M | = Maintained | Details |
| 2018 | N/A | N/A | $385.00M – 390.00M | N/A | = Maintained | Details |
| 2018 | N/A | N/A | $385.00M – 390.00M | $386.88M | = Maintained | Details |
| 2018 | N/A | N/A | $400.00M – 410.00M | $405.47M | = Maintained | Details |
| Q2 2018 | N/A | N/A | $400.00M – 410.00M | N/A | = Maintained | Details |
| 2017 | N/A | N/A | $315.00M – 320.00M | N/A | = Maintained | Details |
| 2017 | N/A | N/A | $310.00M – 320.00M | N/A | = Maintained | Details |
| Q3 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q2 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| 2016 | N/A | N/A | $210.00M – 220.00M | $188.70M | = Maintained | Details |
| 2016 | N/A | N/A | $175.00M – 185.00M | $165.97M |  Raised |
Details |
| 2016 | N/A | N/A | $155.00M – 165.00M | $150.00M | Raised |
Details |
| Q4 2016 | N/A | N/A | $220.00M – 225.00M | $222.20M | = Maintained | Details |
